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Background
Surveillance of resistance to antimalarials is a priority in the
light of limited therapeutic options against P. falciparum
and the emergence of artemisinin resistant strains. In some
countries, antifolates and 4-aminoquinolines might remain
a second line choice therapy, mainly in particular clinical
situations or when availability of artemisinin combined
therapy (ACT) is limited. During the past decade, we have
monitored the status of antimalarial resistance associated
genes in the northwest region of Colombia, where both
vivax and falciparum malaria are highly endemic. Treat-
ment for P. falciparum infection in Colombia is based on
ACT, and for P. vivax, on choloroquine plus primaquine.
Some authors have reported pregnant subjects as an impor-
tant reservoir of P. falciparum resistant clones, mainly as a
consequence of Intermittent preventive treatment in preg-
nancy (IPTp). In the light of the recent reports made in
Colombia of a higher than expected frequency of pregnancy
associated malaria, efforts were directed to study the
genetic characteristics of the P. falciparum and P. vivax
alleles associated with antifolate resistance in pregnant and
non-pregnant populations of the country.
Materials and methods
A sample size sample of 20 isolates of P. vivax and 20 of
P. falciparum was proposed and grouped into 1) parturi-
ent with a positive peripheral blood test, 2) positive pla-
cental blood, 3) gestational malaria (non-parturient) and
4) positive non-pregnant subject. The genes dhfr, dhps
and mdr1 were assessed for both species. For this, PCR
followed by direct sequencing was performed in each
gene. Analysis of the sequences was carried out using
Genious 6.1.3.
Results
Successful DNA amplification was observed in 20
P. vivax and in 15 P. falciparum samples. In 19/20
P. vivax, the triple mutant Pvdhfr (58R, 117N) and
Pvdhps (383G) was detected. Similarly, for P. falci-
parum, 14/15 isolates exhibited the triple mutant geno-
type Pfdhfr (51I, 108N) and Pfdhps (437G). Assessment
of the Pvmdr1 gene confirmed presence of the wild type
alleles Y976 and F1076 in 19/20 samples. A double
mutant (976F, 1076L) was observed in a pregnant
woman. As for Pfmdr1, all samples presented the haplo-
type N86, 184F. Distribution of the different genotypes
was similar in all groups.
Conclusions
Over 90% of P. falciparum samples, regardless of the
group of study, exhibited mutant alleles of Pfdhps, Pfdhfr y
Pfmdr1. Pvmdr1 remains wild-type in all groups studied.
A triple-mutant pattern of resistance in antifolat-related
genes was observed in P. vivax and P. falciparum. This
renders antifolates a non-viable option for a IPTp policy in
the country.
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